BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24268129)

  • 1. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer.
    Hall NJ; Rubin GP; Dobson C; Weller D; Wardle J; Ritchie M; Rees CJ
    Health Expect; 2015 Oct; 18(5):1645-57. PubMed ID: 24268129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
    Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
    BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gender on decisions to participate in faecal immunochemical test-based colorectal cancer screening: a qualitative study.
    Clarke N; Gallagher P; Kearney PM; McNamara D; Sharp L
    Psychooncology; 2016 Dec; 25(12):1456-1462. PubMed ID: 26864167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial.
    Guiriguet-Capdevila C; Muñoz-Ortiz L; Rivero-Franco I; Vela-Vallespín C; Vilarrubí-Estrella M; Torres-Salinas M; Grau-Cano J; Burón-Pust A; Hernández-Rodríguez C; Fuentes-Peláez A; Reina-Rodríguez D; De León-Gallo R; Mendez-Boo L; Torán-Monserrat P
    BMC Cancer; 2014 Mar; 14():232. PubMed ID: 24685117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
    Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
    Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening knowledge, attitudes and behavioural intention among Indigenous Western Australians.
    Christou A; Thompson SC
    BMC Public Health; 2012 Jul; 12():528. PubMed ID: 22809457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
    Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
    Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
    Dharni N; Armstrong D; Chung-Faye G; Wright AJ
    Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative emotions and cancer fatalism are independently associated with uptake of Faecal Immunochemical Test-based colorectal cancer screening: Results from a population-based study.
    Clarke N; Kearney PM; Gallagher P; McNamara D; O'Morain CA; Sharp L
    Prev Med; 2021 Apr; 145():106430. PubMed ID: 33482227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors related to longitudinal adherence in colorectal cancer screening: qualitative research findings.
    Benito L; Farre A; Binefa G; Vidal C; Cardona A; Pla M; García M
    Cancer Causes Control; 2018 Jan; 29(1):103-114. PubMed ID: 29170881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Reported And Objectively Recorded Colorectal Cancer Screening Participation In England.
    Lo SH; Waller J; Vrinten C; Wardle J; von Wagner C
    J Med Screen; 2016 Mar; 23(1):17-23. PubMed ID: 26408533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitudes and beliefs regarding colorectal cancer screening among ethnic minority groups in the Netherlands - a qualitative study.
    Woudstra AJ; Dekker E; Essink-Bot ML; Suurmond J
    Health Expect; 2016 Dec; 19(6):1312-1323. PubMed ID: 26576015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes towards and beliefs about colorectal cancer and screening using the faecal occult blood test within the Italian-Australian community.
    Severino G; Wilson C; Turnbull D; Duncan A; Gregory T
    Asian Pac J Cancer Prev; 2009; 10(3):387-94. PubMed ID: 19640179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do some participants in colorectal cancer screening choose not to undergo colonoscopy following a positive test result? A qualitative study.
    Bie AKL; Brodersen J
    Scand J Prim Health Care; 2018 Sep; 36(3):262-271. PubMed ID: 30238859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.